Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1

Balázs I. Tóth, Nóra Dobrosi, Angéla Dajnoki, G. Czifra, Attila Oláh, Attila G. Szöllsi, I. Juhász, Koji Sugawara, Ralf Paus, T. Bíró

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

We have recently shown that lipid mediators of the emerging endocannabinoid system (ECS) are key players of growth control of the human pilosebaceous unit. In this study, we asked whether the prototypic endocannabinoid anandamide (N-arachidonoylethanolamine, AEA) has a role in growth and survival of epidermal keratinocytes (KCs). Using human cultured KCs and skin organ-culture models, and by employing combined pharmacological and molecular approaches, we provide early evidence that AEA markedly suppresses KC proliferation and induces cell death, both in vitro and in situ. Moreover, we present that these cellular actions are mediated by a most probably constitutively active signaling mechanism that involves the activation of the metabotropic cannabinoid receptor CB 1 and a sequential engagement of the ionotropic cannabinoid receptor transient receptor potential vanilloid-1 (TRPV1). Finally, we demonstrate that the cellular effects of AEA are most probably due to a Ca2+ influx via the non-selective, highly Ca2+-permeable ion channel TRPV1, and the concomitant elevation of intracellular Ca2+ concentration. The data reported here may encourage one to explore whether the targeted manipulation of the above signaling pathway of the cutaneous ECS could become a useful adjunct treatment strategy for hyperproliferative human dermatoses such as psoriasis or KC-derived skin tumors.

Original languageEnglish
Pages (from-to)1095-1104
Number of pages10
JournalJournal of Investigative Dermatology
Volume131
Issue number5
DOIs
Publication statusPublished - May 2011

Fingerprint

Cannabinoid Receptors
Endocannabinoids
Keratinocytes
Survival
Skin
Organ Culture Techniques
Cell death
Growth
Ion Channels
Psoriasis
Skin Diseases
Tumors
Cell Death
Chemical activation
Pharmacology
Lipids
vanilloid receptor subtype 1
N-arachidonoylethanolamine
Neoplasms

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. / Tóth, Balázs I.; Dobrosi, Nóra; Dajnoki, Angéla; Czifra, G.; Oláh, Attila; Szöllsi, Attila G.; Juhász, I.; Sugawara, Koji; Paus, Ralf; Bíró, T.

In: Journal of Investigative Dermatology, Vol. 131, No. 5, 05.2011, p. 1095-1104.

Research output: Contribution to journalArticle

@article{e7c5398f7f4549c8bb90a38df19bc228,
title = "Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1",
abstract = "We have recently shown that lipid mediators of the emerging endocannabinoid system (ECS) are key players of growth control of the human pilosebaceous unit. In this study, we asked whether the prototypic endocannabinoid anandamide (N-arachidonoylethanolamine, AEA) has a role in growth and survival of epidermal keratinocytes (KCs). Using human cultured KCs and skin organ-culture models, and by employing combined pharmacological and molecular approaches, we provide early evidence that AEA markedly suppresses KC proliferation and induces cell death, both in vitro and in situ. Moreover, we present that these cellular actions are mediated by a most probably constitutively active signaling mechanism that involves the activation of the metabotropic cannabinoid receptor CB 1 and a sequential engagement of the ionotropic cannabinoid receptor transient receptor potential vanilloid-1 (TRPV1). Finally, we demonstrate that the cellular effects of AEA are most probably due to a Ca2+ influx via the non-selective, highly Ca2+-permeable ion channel TRPV1, and the concomitant elevation of intracellular Ca2+ concentration. The data reported here may encourage one to explore whether the targeted manipulation of the above signaling pathway of the cutaneous ECS could become a useful adjunct treatment strategy for hyperproliferative human dermatoses such as psoriasis or KC-derived skin tumors.",
author = "T{\'o}th, {Bal{\'a}zs I.} and N{\'o}ra Dobrosi and Ang{\'e}la Dajnoki and G. Czifra and Attila Ol{\'a}h and Sz{\"o}llsi, {Attila G.} and I. Juh{\'a}sz and Koji Sugawara and Ralf Paus and T. B{\'i}r{\'o}",
year = "2011",
month = "5",
doi = "10.1038/jid.2010.421",
language = "English",
volume = "131",
pages = "1095--1104",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1

AU - Tóth, Balázs I.

AU - Dobrosi, Nóra

AU - Dajnoki, Angéla

AU - Czifra, G.

AU - Oláh, Attila

AU - Szöllsi, Attila G.

AU - Juhász, I.

AU - Sugawara, Koji

AU - Paus, Ralf

AU - Bíró, T.

PY - 2011/5

Y1 - 2011/5

N2 - We have recently shown that lipid mediators of the emerging endocannabinoid system (ECS) are key players of growth control of the human pilosebaceous unit. In this study, we asked whether the prototypic endocannabinoid anandamide (N-arachidonoylethanolamine, AEA) has a role in growth and survival of epidermal keratinocytes (KCs). Using human cultured KCs and skin organ-culture models, and by employing combined pharmacological and molecular approaches, we provide early evidence that AEA markedly suppresses KC proliferation and induces cell death, both in vitro and in situ. Moreover, we present that these cellular actions are mediated by a most probably constitutively active signaling mechanism that involves the activation of the metabotropic cannabinoid receptor CB 1 and a sequential engagement of the ionotropic cannabinoid receptor transient receptor potential vanilloid-1 (TRPV1). Finally, we demonstrate that the cellular effects of AEA are most probably due to a Ca2+ influx via the non-selective, highly Ca2+-permeable ion channel TRPV1, and the concomitant elevation of intracellular Ca2+ concentration. The data reported here may encourage one to explore whether the targeted manipulation of the above signaling pathway of the cutaneous ECS could become a useful adjunct treatment strategy for hyperproliferative human dermatoses such as psoriasis or KC-derived skin tumors.

AB - We have recently shown that lipid mediators of the emerging endocannabinoid system (ECS) are key players of growth control of the human pilosebaceous unit. In this study, we asked whether the prototypic endocannabinoid anandamide (N-arachidonoylethanolamine, AEA) has a role in growth and survival of epidermal keratinocytes (KCs). Using human cultured KCs and skin organ-culture models, and by employing combined pharmacological and molecular approaches, we provide early evidence that AEA markedly suppresses KC proliferation and induces cell death, both in vitro and in situ. Moreover, we present that these cellular actions are mediated by a most probably constitutively active signaling mechanism that involves the activation of the metabotropic cannabinoid receptor CB 1 and a sequential engagement of the ionotropic cannabinoid receptor transient receptor potential vanilloid-1 (TRPV1). Finally, we demonstrate that the cellular effects of AEA are most probably due to a Ca2+ influx via the non-selective, highly Ca2+-permeable ion channel TRPV1, and the concomitant elevation of intracellular Ca2+ concentration. The data reported here may encourage one to explore whether the targeted manipulation of the above signaling pathway of the cutaneous ECS could become a useful adjunct treatment strategy for hyperproliferative human dermatoses such as psoriasis or KC-derived skin tumors.

UR - http://www.scopus.com/inward/record.url?scp=79954952532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954952532&partnerID=8YFLogxK

U2 - 10.1038/jid.2010.421

DO - 10.1038/jid.2010.421

M3 - Article

VL - 131

SP - 1095

EP - 1104

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5

ER -